UM-HACC-2A Cells

TECHNOLOGY NUMBER: 2021-293
Technology No. 2021-293
CELLS
1

OVERVIEW

The UM-HACC-2A cells are the first fusion positive (MYB-NFIB) adenoid cystic carcinoma cell (ACC) line generated and were developed from a human with a T3N1M0 ACC in their minor salivary gland. They are transplantable, metastatic, and cisplatin-resistant.


ADDITIONAL DETAILS

Order from Applied Biological Materials:

https://www.abmgood.com/um-hacc-2a-cells.html#hacc-2a)

  • swap_vertical_circlemode_editInventor (2)
    Jacques Nor
    Kristy Warner
  • swap_vertical_circlecloud_downloadSupporting documents (1)
    Product brochure
    UM-HACC-2A Cells.pdf
    DOWNLOAD
Questions about this technology?
Contact us